You are about to leave the website of Otsuka Novel Products GmbH and view the content of an external website. Otsuka Novel Products GmbH cannot be held responsible for the content of external websites.
Otsuka collaborates with academic and non-profit research institutions and other private companies on truly paradigm-shifting technologies.
Otsuka is a member of the Project to Accelerate New Treatments for Tuberculosis (PAN-TB Collaboration). It is a consortium of philanthropic, non-profit and private sector organisations who aim to develop treatment regimens for TB patients, no matter their drug resistance status.
Otsuka is also a member of UNITE4TB (academia and industry united innovation and treatment for tuberculosis), a global public-private consortium of academic institutions, pharmaceutical companies, and research organizations, working together on accelerating the development of new treatment regimens for tuberculosis.
Information current as of March 2026
Reference ONP-DEL-2500003 v2.0